Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04501861 · ClinicalTrials.gov registry record · Phase 3
Hemodynamic Effect of Norepinephrine Versus Vasopressin on the Pulmonary Circulation in Cardiac Surgery Patients:
A Phase 3 study of Cardiac Disease, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 153
- Enrollment target
- 1
- Study location
NCT04501861 is a Phase 3 study of Cardiac Disease that has completed, run by The Cleveland Clinic. The registered enrollment target is 153 participants, below the 816-participant average among 24 other Cardiac Disease trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04501861, a Phase 3 study of Cardiac Disease, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 153 participants
- Enrollment target
- 1
- Study location
Study Summary
The relative increase in the mPAP with the same unit increase in MAP adjusted for baseline, and RV function assessed by GLS, between VP and NE in patients with normal and increased pulmonary artery pressure, who require vasopressor support during cardiac surgery.
Conditions Studied
Interventions
- DRUG Norepinephrine
- DRUG Vasopressin
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2020-11-05 |
| Est. Completion | 2024-12-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04501861
The ClinicalTrials.gov registry entry for NCT04501861 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 816-participant average among 24 other Cardiac Disease trials with a reported enrollment target (81% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiac Disease appearing as the primary indexed condition, and to 2 interventions - of which Norepinephrine is the first listed.
NCT04501861 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04501861 about?
NCT04501861 is a clinical study titled "Hemodynamic Effect of Norepinephrine Versus Vasopressin on the Pulmonary Circulation in Cardiac Surgery Patients:". The relative increase in the mPAP with the same unit increase in MAP adjusted for baseline, and RV function assessed by GLS, between VP and NE in patients with normal and increased pulmonary artery pressure, who require vasopressor support during cardiac surgery.
What is the current status of trial NCT04501861?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 153 participants. The study started on 2020-11-05. Estimated completion is 2024-12-31.
What conditions does trial NCT04501861 study?
This clinical trial studies the following conditions: Cardiac Disease.
What interventions are being tested in trial NCT04501861?
The interventions under investigation include: Norepinephrine (DRUG), Vasopressin (DRUG).
Who is sponsoring clinical trial NCT04501861?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04501861 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE
ACTIVE NOT RECRUITING · Phase 3
-
DEF-314 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY
COMPLETED · Phase 3
-
Cardiac Performance System Data Collection Study - Minnesota
RECRUITING
-
A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening
RECRUITING
-
Fresh Autologous Whole Blood Transfusion After Cardiopulmonary Bypass
RECRUITING · NA
-
Rectus Sheath Block in Cardiac Surgery
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.